Verano to acquire Connecticut Pharmaceutical Solutions from Tuatara Capital for $113m.

Verano, a multi-state cannabis company, agreed to acquire Connecticut Pharmaceutical Solutions, a cultivation and production company, from Tuatara Capital, a private equity firm, for $113m. "We are excited about the continued expansion of both our national platform and our East Coast hub. Entering the Connecticut market ahead of its adult-use transition provides a clear runway for sustainable, long-term growth. These acquisitions are well-aligned with our broader growth strategy, and further strengthen our operational bandwidth by bringing management teams on board that have demonstrated multi-disciplinary savvy and a keen understanding of the Connecticut market in both the retail and wholesale channels," George Archos, Verano Founder and CEO.